Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 19;48(5):e20220127.
doi: 10.36416/1806-3756/e20220127.

Inflammatory myofibroblastic tumor of the lung - an explosive metastatic case

[Article in English, Portuguese]
Henrique Cabrita Rodrigues  1 , Wanda Videira  1 , Luís Rodrigues  1 , Rita Pinheiro  1 , Filipa Ferro  1
Affiliations

Inflammatory myofibroblastic tumor of the lung - an explosive metastatic case

[Article in English, Portuguese]
Henrique Cabrita Rodrigues et al. J Bras Pneumol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Computed tomography (CT) images. A - Left pulmonary apex with necrotic and abcessed tissue. B - Hepatic abcessed/nodular lesion with necrotic component.
See this image and copyright information in PMC

References

    1. Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KSJ, Perlman E, Griffin CA. ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor. Mod Pathol. 2001;14(6):569–576. doi: 10.1038/modpathol.3880352. - DOI - PubMed
    1. Jo VY, Fletcher CDM. WHO classification of soft tissue tumours an update based on the 2013 (4th) edition. Pathology. 2014;46(2):95–104. doi: 10.1097/PAT.0000000000000050. - DOI - PubMed
    1. Al-Obaidi A, Buess C, Mogire J, Reddy PS. Inflammatory Myofibroblastic Tumor of the Lung An Extremely Rare Condition in Adults. Cureus. 2019;11(12):e5432. doi: 10.7759/cureus.6432. - DOI - PMC - PubMed
    1. Khalil S, Ghafoor T, Raja AKF. Inflammatory Myofibroblastic Tumor A Rare Presentation and an Effective Treatment with Crizotinib. Case Rep Oncol Med. 2020;2020:6923103–6923103. doi: 10.1155/2020/6923103. - DOI - PMC - PubMed
    1. Alan O, Kuzhan O, Koca S, Telli TA, Basoglu T, Ercelep O. How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors Long-term complete response with crizotinib and review of the literature. J Oncol Pharm Pract. 2020;26(4):1011–1018. doi: 10.1177/1078155219879757. - DOI - PubMed